Neuro AI
ArterysProduct specifications |
Information source:
Vendor
Last updated: May 6, 2022 |
General | |
---|---|
Product name | Neuro AI |
Company | Arterys |
Subspeciality | Neuro |
Modality | CT, MR |
Disease targeted | Intracranial Hemorrhage, Stroke, brain oncology, brain tumours, aneurysms, stenosis, multiple sclerosis (MS), neurodegenerative disease, Alzheimer's disease, dementia |
Key-features | Large vessel occlusion detection, hemorrhage detection, notification, MRI-DSC post-processing, generation of perfusion parameter maps and vascular input function (rCBV, rCBF Tmax, MTT, Time to Peak, kTrans, kVp, deltaT1), 4D flow visualization and quantification of intracranial vessels, brain volumetry, white matter lesion quantification |
Suggested use | Before: flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion After: diagnosis verification |
Data characteristics | |
Population | Adult patients suspected of stroke, all patients suspected with or diagnosed with brain tumor, all patients with neurological disorders |
Input | Multi-parametric MRI including DSC, DCE and diffusion MRI and pre/post contrast T1, non-contrast CT, CTA |
Input format | DICOM |
Output | Multi-parametric MR maps, bounding box for stroke and hemorrhage location, 4D flow visualization, notification, report |
Output format | DICOM, secondary capture, viewer objects |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc., Auto-routing from PACS |
Processing time | < 3 sec |
Certification | |
CE
|
Certified,
Class IIa
, MDD/MDR
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 12-2020 |
Distribution channels | Humanbyte, Wellbeing Software’s AI Connect Marketplace, RMS Medical Devices |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of users, Number of analyses |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |